|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,75,200.00 KRW | +1.21% |
|
-4.58% | +1.64% |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| 03/07 | South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains | MT |
EPS & Dividend: Celltrion, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 628.9 | - | 436.1 | 686.8 | 714.3 | 736 | 799.7 | 860.4 |
| Rate of return | 0.38% | - | 0.25% | 0.4% | 0.41% | 0.42% | 0.46% | 0.49% |
| EPS 2 | 3,515 | 3,362 | 3,273 | 1,873 | 4,438 | 6,476 | 7,308 | 8,402 |
| Distribution rate | 17.9% | - | 13.3% | 36.7% | 16.1% | 11.4% | 10.9% | 10.2% |
| Reference price 2 | 1,66,042.75 | 1,39,979.07 | 1,75,736.96 | 1,71,703.30 | 1,72,380.95 | 1,75,200.00 | 1,75,200.00 | 1,75,200.00 |
| Nbr of stocks (in thousands) | 1,66,178 | 1,64,313 | 1,59,160 | 2,35,088 | 2,29,737 | 2,29,327 | - | - |
| Announcement Date | 16/02/22 | 03/03/23 | 29/02/24 | 25/02/25 | 04/02/26 | - | - | - |
1KRW in Million2KRW
Estimates
Past dividends: Celltrion, Inc.
| 04/06/2026 | Significant Split/Dividend | 09:30 am |
| 29/12/2025 | Ex-dividend date for special dividend - 750 KRW | 10:30 am |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| 0.43% | 0.46% | 26.73x | 2.18x | 7.84x | ||
| 0.94% | 1.07% | 35.02x | 4.44x | 6.15x | ||
| -.--% | -.--% | -23.93x | 18.81x | 350.56x | ||
| -.--% | -.--% | 25.43x | 4.82x | 2.81x | ||
| -.--% | -.--% | 46.36x | 6.78x | 4.58x | ||
| - | - | - | - | 10.23x | ||
| -.--% | -.--% | 31.59x | 15.74x | 5.09x | ||
| 1.12% | 1.31% | 23.89x | 2.5x | 2.03x | ||
| -.--% | -.--% | 23.89x | 1.33x | 1.9x | ||
| -.--% | -.--% | -33.54x | 10.17x | 128.5x | ||
| Average | 0.28% | 0.32% | 17.27x | 7.42x | 51.97x | |
| Weighted average by Cap. | 0.31% | 0.35% | 19.42x | 7.74x | 65.63x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















